Le Vu Stéphane, Aquatias Sylvain, Bonnet Nicolas, Debrus Marie, Fournier Gilbert, Beauverie Patrick
Mission XBT, Médecins du Monde, Paris (75).
Presse Med. 2006 May;35(5 Pt 1):755-8. doi: 10.1016/s0755-4982(06)74685-1.
There is little information available about the real content of cannabis consumed in France.
To assess the chemical content, including adulterants and contaminants, and potency of cannabis samples obtained from end-users.
Samples of resins considered by users to produce "unusual" effects were collected from habitual consumers and chemically analyzed.
Thirty-seven samples were obtained. Average THC content was 8.8%. The effects reported by users were consistent with the THC content. Apart from an unidentified fatty substance found in two samples, no adulteration was found.
This study, which relied on volunteers, enabled us to collect samples considered abnormal by experienced users. It did not confirm the numerous anecdotes of adulteration.
We suggest that this study should be widened to monitor the current chemical contents of cannabis derivatives available in France. The impact of providing users with the results remains to be evaluated.
关于法国消费的大麻实际成分的信息很少。
评估从最终用户处获得的大麻样本的化学成分，包括掺假物和污染物，以及效力。
从习惯性消费者那里收集被用户认为会产生“异常”效果的树脂样本，并进行化学分析。
获得了37个样本。四氢大麻酚（THC）平均含量为8.8%。用户报告的效果与THC含量一致。除了在两个样本中发现一种不明脂肪物质外，未发现掺假情况。
这项依赖志愿者的研究使我们能够收集有经验的用户认为异常的样本。它没有证实众多关于掺假的传闻。
我们建议应扩大这项研究，以监测法国现有的大麻衍生物的当前化学成分。向用户提供结果的影响仍有待评估。
